Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an organic basis,
Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results
Categories
pharmaceuticals
Ocean Biomedical forms JV with Virion Therapeutics to find treatments for cancer and chronic infectious diseases
Biotechnology company Ocean Biomedical, Inc. (NASDAQ: OCEA) entered into a joint venture with Virion Therapeutics, LLC, to expedite and expand the latter’s
Johnson & Johnson to report earnings on Oct 17. Here’s what to look for
After reporting better-than-expected quarterly earnings consistently for over a decade, healthcare behemoth Johnson & Johnson (NYSE: JNJ) is preparing to release its
UnitedHealth earnings preview: Another beat in cards despite cost concerns
Over the years, UnitedHealth Group Incorporated (NYSE: UNH) has expanded steadily through diversification and acquisitions, all along creating value for shareholders. The
What to look for when Walgreens Boots Alliance reports earnings on Oct. 12
Retail pharmacy chain Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is on the path to a transformation as it looks to align the
Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers to develop and commercialize their discoveries,
Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the healthcare
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates
Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues. Third-quarter revenue
Ocean Biomedical (OCEA) announces new patent for anti-fibrosis discovery
Ocean Biomedical, Inc. (NASDAQ: OCEA), a leading biopharma company that works to accelerate the development and commercialization of scientifically compelling assets from
MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal
Cardinal Health Inc Q4 2023 Earnings Conference Call Insights
Key highlights from Cardinal Health Inc (CAH) Q4 2023 Earnings Concall Management Update: [00:02:00] CAH delivered record financial performance, including its highest
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that operates by partnering with leading researchers to accelerate new discoveries in the
Earnings Summary: Highlights of Cardinal Health’s (CAH) Q4 2023 results
Pharmaceuticals distributor Cardinal Health (NYSE: CAH) announced financial results for the fourth quarter of 2023, reporting higher revenues and adjusted profit. Revenues
Illumina, Inc Q2 2023 Earnings Conference Call Insights
Key highlights from Illumina, Inc (ILMN) Q2 2023 Earnings Concall Management Update: [00:07:42] ILMN now expects to ship more than 390 NovaSeq
Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers
Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday provided an update on its broad range of programs in malaria, fibrosis, and multiple cancers.
Earnings Summary: Highlights of Illumina’s Q2 2023 results
Biotechnology company Illumina, Inc. (NASDAQ: ILMN) on Wednesday announced financial results for the second quarter of 2023. Second-quarter revenue came in at
Earnings Summary: Highlights of Organon’s Q2 2023 results
Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and earnings for the second quarter of 2023. Second-quarter revenue came
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights
Key highlights from Charles River Laboratories International, Inc (CRL) Q2 2023 Earnings Concall Q&A Highlights: [00:34:34] Sandy Draper with Guggenheim asked if
Earnings Summary: Charles River Laboratories reports Q2 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the second quarter of 2023. For the
Trxade Health Inc. (NASDAQ: MEDS) Q2 2023 Research Summary
Trxade Health Inc. (NASDAQ: MEDS) is a healthcare IT company that constantly innovates and expands into new verticals, with the latest such